Published in Br J Pharmacol on May 01, 2005
Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem (2008) 1.06
Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels. Hippocampus (2012) 0.93
Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One (2013) 0.89
Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br J Pharmacol (2011) 0.87
Protonophore properties of hyperforin are essential for its pharmacological activity. Sci Rep (2014) 0.79
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
TRP channels as cellular sensors. Nature (2003) 12.03
The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ Res (2001) 5.04
SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J (1990) 3.86
Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry. J Biol Chem (1998) 2.32
Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood (2002) 2.16
Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes. J Biol Chem (1989) 2.10
Lanthanides potentiate TRPC5 currents by an action at extracellular sites close to the pore mouth. J Biol Chem (2002) 1.91
St John's wort: Prozac from the plant kingdom. Trends Pharmacol Sci (2001) 1.91
A molecular description of nerve terminal function. Annu Rev Biochem (1983) 1.82
Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem J (1999) 1.79
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas. FEBS Lett (1990) 1.76
Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci (2002) 1.63
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res (1995) 1.51
Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch (1994) 1.47
Inhibition by SK&F 96365 of Ca2+ current, IL-2 production and activation in T lymphocytes. Br J Pharmacol (1994) 1.47
Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci (1998) 1.25
A diacylglycerol-activated Ca2+ channel in PC12 cells (an adrenal chromaffin cell line) correlates with expression of the TRP-6 (transient receptor potential) protein. Biochem J (2001) 1.15
Muscarinic acetylcholine receptor regulation of TRP6 Ca2+ channel isoforms. Molecular structures and functional characterization. J Biol Chem (2001) 1.13
Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharmacol Exp Ther (1999) 0.91
Pharmacology of a Ca(2+)-influx pathway activated by emptying the intracellular Ca2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved. Biochem J (1994) 0.91
Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett (1999) 0.90
Kinetic properties of the sodium-calcium exchanger in rat brain synaptosomes. J Physiol (1995) 0.87
Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry (2001) 0.84
Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane. Life Sci (2003) 0.84
Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity. Pharmacopsychiatry (2001) 0.83
Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Psychopharmacology (Berl) (2002) 0.83
Resting and ADP-evoked changes in cytosolic free sodium concentration in human platelets loaded with the indicator SBFI. J Physiol (1991) 0.83
Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C. J Neurosci (2003) 0.83
Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol (2004) 0.82
Retracted Primary structure and functional expression of a novel non-selective cation channel. Biochem Biophys Res Commun (1998) 0.82
Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology (2000) 0.82
Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort. Pharmacopsychiatry (2001) 0.81
Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin. Biochem Pharmacol (2003) 0.80
Characterization of G proteins involved in activation of nonselective cation channels by endothelin(B) receptor. Br J Pharmacol (2002) 0.80
Adhyperforin as a contributor to the effect of Hypericum perforatum L. in biochemical models of antidepressant activity. Life Sci (2001) 0.80
Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort. J Pharmacol Exp Ther (2002) 0.80
Thrombin and NaF, but not epinephrine, raise cytosolic free Na+ in human platelets. Biochim Biophys Acta (1993) 0.78
Biochemical mechanisms of action of Hypericum LI 160 in glial and neuronal cells: inhibition of neurotransmitter uptake and stimulation of extracellular signal regulated protein kinase. Pharmacopsychiatry (2001) 0.77
In vivo neurotransmitter release in the locus coeruleus--effects of hyperforin, inescapable shock and fear. Pharmacopsychiatry (2001) 0.77
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One (2009) 1.71
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem (2005) 1.64
Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic Biol Med (2005) 1.51
Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener Dis (2008) 1.42
Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J (2007) 1.31
Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem (2004) 1.28
Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal (2007) 1.28
Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol (2003) 1.24
Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. J Mol Med (Berl) (2008) 1.23
Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem (2007) 1.16
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther (2004) 1.16
Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol (2002) 1.13
Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal (2012) 1.12
Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacol Res (2007) 1.11
Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis (2009) 1.09
Tocotrienols: constitutional effects in aging and disease. J Nutr (2005) 1.09
From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol Neurobiol (2012) 1.07
Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem (2008) 1.06
Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci (2010) 1.05
Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann N Y Acad Sci (2003) 1.04
Age-related impairment of human T lymphocytes' activation: specific differences between CD4(+) and CD8(+) subsets. Mech Ageing Dev (2002) 1.04
Lipid rafts of purified mouse brain synaptosomes prepared with or without detergent reveal different lipid and protein domains. Brain Res (2003) 1.01
Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol (2006) 1.01
Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann N Y Acad Sci (2005) 1.00
A new link to mitochondrial impairment in tauopathies. Mol Neurobiol (2012) 1.00
Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes. Mol Neurobiol (2012) 0.99
Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res (2009) 0.99
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials. Wien Med Wochenschr (2010) 0.99
Isoprenoids, small GTPases and Alzheimer's disease. Biochim Biophys Acta (2010) 0.98
Cholesterol asymmetry in synaptic plasma membranes. J Neurochem (2011) 0.96
Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis (2006) 0.96
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol (2010) 0.96
The amyloid precursor protein protects PC12 cells against endoplasmic reticulum stress-induced apoptosis. J Neurochem (2003) 0.95
Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis (2005) 0.95
Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim Biophys Acta (2003) 0.94
Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6. J Invest Dermatol (2010) 0.93
Cholesterol: Coupling between membrane microenvironment and ABC transporter activity. Biochem Biophys Res Commun (2007) 0.93
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin. Int J Clin Pharmacol Ther (2012) 0.92
Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease. Exp Gerontol (2006) 0.91
Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing. Biochim Biophys Acta (2010) 0.90
Effects of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology (2006) 0.90
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J Neurochem (2014) 0.90
Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One (2013) 0.89
Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP). Anal Bioanal Chem (2008) 0.89
Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One (2011) 0.89
Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos (2008) 0.89
The amyloid precursor protein potentiates CHOP induction and cell death in response to ER Ca2+ depletion. Biochim Biophys Acta (2006) 0.87
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression. Int Clin Psychopharmacol (2010) 0.87
Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective study using the DAPI database. J Hypertens (2011) 0.87
Comparison of olecranon plate fixation in osteoporotic bone: do current technologies and designs make a difference? J Orthop Trauma (2011) 0.87
The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim Biophys Acta (2009) 0.86
A biomechanical comparison of multidirectional nail and locking plate fixation in unstable olecranon fractures. J Shoulder Elbow Surg (2011) 0.85
Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. Neurochem Int (2013) 0.85
Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy. Neuromolecular Med (2007) 0.84
Hydroxytyrosol-rich olive mill wastewater extract protects brain cells in vitro and ex vivo. J Agric Food Chem (2007) 0.84
Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol (2010) 0.83
Cardiac oxidative stress and inflammation are similar in SAMP8 and SAMR1 mice and unaltered by curcumin and Ginkgo biloba extract intake. Curr Pharm Biotechnol (2010) 0.82
Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's APP mutation and sensitizes cells to staurosporine-induced cell death. J Mol Neurosci (2002) 0.82
Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol (2004) 0.82
Is hypercholesterolemia a risk factor for Alzheimer's disease? Mol Neurobiol (2005) 0.81
Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam. Front Neurosci (2010) 0.81
TRPC6 channel-mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling. J Neurochem (2013) 0.81
Before the breaking point: reducing the risk of osteoporotic fracture. J Am Osteopath Assoc (2013) 0.81
Mitochondrial dysfunction induced by disease relevant AbetaPP and tau protein mutations. J Alzheimers Dis (2006) 0.80
Cholesterol modulates amyloid beta-peptide's membrane interactions. Pharmacopsychiatry (2003) 0.80
Plant derived omega-3-fatty acids protect mitochondrial function in the brain. Pharmacol Res (2010) 0.80
Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin. Biochem Pharmacol (2003) 0.80
Expression and functional activity of the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes. Skin Pharmacol Physiol (2015) 0.79
Modulation of Pgp function by boswellic acids. Planta Med (2006) 0.79
Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: a research perspective. Int Psychogeriatr (2012) 0.79
A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS. Anal Bioanal Chem (2010) 0.78
Heterologously expressed GLT-1 associates in approximately 200-nm protein-lipid islands. Biophys J (2006) 0.78
Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production. Mol Neurobiol (2010) 0.78
Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam. Biochem Soc Trans (2013) 0.78
[Overview of phytopharmaceuticals for therapy of dementia. Quality and activity of Gingko biloba extract]. Pharm Unserer Zeit (2002) 0.77
Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease. Neuromolecular Med (2003) 0.77
Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem (2003) 0.77
Cytoprotective effects of olive mill wastewater extract and its main constituent hydroxytyrosol in PC12 cells. Pharmacol Res (2010) 0.77
Hyperforin modifies neuronal membrane properties in vivo. Neurosci Lett (2004) 0.76
Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation. Mol Nutr Food Res (2007) 0.76
Hypochlorous acid scavenging properties of local Mediterranean plant foods. Lipids (2004) 0.76
Presenilin 1 modifies lipid raft composition of neuronal membranes. Biochem Biophys Res Commun (2009) 0.76
[Editorial: atypical neuroleptics]. Pharm Unserer Zeit (2002) 0.75
[Antacids and H2 antihistaminics for hyperacidity]. Pharm Unserer Zeit (2007) 0.75
Quantifying and comparing torsional strains after olecranon plating. Injury (2012) 0.75
Adherence to antihypertensives: feasibility of two self-report instruments to investigate medication-taking behaviour in German community pharmacies. Int J Pharm Pract (2012) 0.75
[Collagenin and collagen]. Pharm Unserer Zeit (2004) 0.75
Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin. Rapid Commun Mass Spectrom (2006) 0.75
[Tricyclics as co-analgesics. Therapeutic options for chronic pain]. Pharm Unserer Zeit (2008) 0.75
[Minerals and trace elements--a case for discussion]. Pharm Unserer Zeit (2009) 0.75
Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology. J Neural Transm (Vienna) (2015) 0.75